Granules India Limited



Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled “Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)”. |SUBJECT: Press Release



Source link

Raj
Author: Raj

Leave a Reply

Your email address will not be published. Required fields are marked *